Hyphens Pharma marks first day of trading with positive gains
Healthcare group ends Catalist debut 5.7 per cent up following opening premium of 15.4%
Singapore
SPECIALITY pharmaceutical and consumer healthcare group Hyphens Pharma International made its trading debut on the Singapore Exchange's Catalist board on Friday at 30 Singapore cents before ending trading at 27.5 Singapore cents.
Its opening salvo, which was 15.4 per cent higher than its 26 Singapore cents initial public offering (IPO) price, …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
China to facilitate Hong Kong IPOs and expand Stock Connect
Global equity funds see surge in outflows as rate cut hopes fade
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
Global wave of consultancy layoffs has not hit Singapore
P&G raises annual core profit forecast on resilient demand, price hikes
American Express’ premium customers help it surpass profit expectations